Can-Fite BioPharma (CANF) EBIT Margin (2015 - 2023)
Can-Fite BioPharma's EBIT Margin was -2456.79% in FY2025, down 1250.56 percentage points from -1206.23% in FY2024.
Powered by 
Analysis
Can-Fite BioPharma (CANF) EBIT Margin (2015 - 2023) Analysis & Trends
From FY2015 onward, Can-Fite BioPharma has reported EBIT Margin for 11 years.
- EBIT Margin shows a five-year change of -603.71 percentage points (FY2020 to FY2025).
- The FY2025 figure marks the lowest annual EBIT Margin in data going back to FY2015.
- Per Business Quant data, EBIT Margin in earlier years was -1206.23% in FY2024 (-103.27 pp), -1102.96% in FY2023 (unchanged), -1102.96% in FY2022 (+402.55 pp) and -1505.51% in FY2021 (+347.57 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | Can-Fite BioPharma | 1.82 Mn | -17.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -1,183.23% |
| Sep 30, 2023 | -951.53% |
| Jun 30, 2023 | -910.20% |
| Mar 31, 2023 | -1,383.67% |
| Dec 31, 2022 | -909.23% |
| Sep 30, 2022 | -1,261.27% |
| Jun 30, 2022 | -1,014.71% |
| Mar 31, 2022 | -1,156.10% |
| Dec 31, 2021 | -1,974.51% |
| Sep 30, 2021 | -1,398.41% |
| Jun 30, 2021 | -1,253.20% |
| Mar 31, 2021 | -1,466.89% |
| Dec 31, 2020 | -2,368.67% |
| Sep 30, 2020 | -1,174.88% |
| Jun 30, 2020 | -1,877.94% |
| Dec 31, 2019 | -2,401.56% |
| Sep 30, 2019 | -242.27% |
| Jun 30, 2019 | -1,623.65% |
| Mar 31, 2019 | 572.24% |
| Dec 31, 2018 | -866.09% |
API Access
Can-Fite BioPharma EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();